Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September
Date:
Presentation Time:
2020
Date:
Presentation Time:
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date:
Fireside
To access a live webcast and subsequent archived recording of each presentation, please visit “Events” in the “Investors” section of the Kala website at http://kalarx.com.
About
Kala is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus penetrating particle Drug Delivery Technology to a corticosteroid, loteprednol etabonate (LE), designed for ocular applications, resulting in the
View source version on businesswire.com: https://www.businesswire.com/news/home/20200908005028/en/
hannah.deresiewicz@sternir.com
212-362-1200
Source: